[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate]
- PMID: 12778857
[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate]
Abstract
Calcitriol deficiency and phosphorus retention are mechanisms involved in the pathogenesis of renal hyperparathyroidism. The aim of this study was to evaluate the effect of dietary phosphorus restriction versus calcium carbonate treatment for one month on PTH and calcitriol levels in patients with mild renal failure. We studied two groups of patients: Group I: 21 patients (14M/7F); mean age 61 years old; mean glomerular filtration rate 51 ml/min. Their diet contained phosphorus 700 mg/day. Group II: 30 patients (21M/9F); mean age 58; mean glomerular rate 56 ml/min. They were divided in two subgroups: 18 patients treated with calcium carbonate 2.5 g/day and 12 patients with 5 g/day. Serum PTH, calcitriol, 25(OH)D3, calcium, phosphorus and urinary excretion of calcium and phosphorus were measured before and after a 30 day period. The low phosphorus diet (Group I) resulted in a significant decrease in PTH levels (81.3 +/- 35 vs 71 +/- 39 pg/ml, p < 0.05) and significant increase in calcitriol levels (22.4 +/- 4.4 vs 33.4 +/- 7.5 pg/ml, p < 0.05). In our study calcium carbonate treatment (Group II) had no effect on PTH and calcitriol levels.
Similar articles
-
The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.Nephrol Dial Transplant. 1996 Aug;11(8):1553-8. Nephrol Dial Transplant. 1996. PMID: 8856210
-
RenaGel efficacy in severe secondary hyperparathyroidism.Nefrologia. 2002;22(5):448-55. Nefrologia. 2002. PMID: 12497746
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.Clin Nephrol. 2000 Oct;54(4):301-8. Clin Nephrol. 2000. PMID: 11076106 Clinical Trial.
-
Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.Miner Electrolyte Metab. 1991;17(4):211-20. Miner Electrolyte Metab. 1991. PMID: 1813783 Review.
Cited by
-
Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.Clin Cases Miner Bone Metab. 2009 Sep;6(3):210-9. Clin Cases Miner Bone Metab. 2009. PMID: 22461248 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical